The severity of Alzheimer’s disease is defined in neuropathology by the presence of tau-based neurofibrillary tangles ranging from early stages (I and II) to extensive neocortical involvement in Braak & Braak stages V and VI in advanced disease. The gene discussed is MAPT; the disease is Alzheimer disease.